Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Cooper

Showing results (281-290 of 324) with videos related to

Pageof 33
Sort By:
AIDS (London, England)|June 15, 2021
Broadly neutralizing antibody responses in the longitudinal primary HIV-1 infection Short Pulse Anti-Retroviral Therapy at Seroconversion cohortLuke A Granger, Isabella Huettner, Franka Debeljak, et al.
The Lancet. HIV|November 6, 2016
Body composition and metabolic outcomes after 96 weeks of treatment with ritonavir-boosted lopinavir plus either nucleoside or nucleotide reverse transcriptase inhibitors or raltegravir in patients with HIV with virological failure of a standard first-line antiretroviral therapy regimen: a substudy of the randomised, open-label, non-inferiority SECOND-LINE studyMark A Boyd, Janaki Amin, Patrick W G Mallon, et al.
The Southeast Asian Journal of Tropical Medicine and Public Health|February 4, 2012
Accelerating the development of an AIDS vaccine: the AIDS vaccine for Asia Network (Avan)Punnee Pitisuttithum, Supachai Rerks-Ngarm, Joseph Chiu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 15, 2018
Risk of Suicidal Behavior With Use of Efavirenz: Results from the Strategic Timing of Antiretroviral Treatment TrialAlejandro Arenas-Pinto, Birgit Grund, Shweta Sharma, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 27, 2005
The TREAT Asia HIV Observational Database: baseline and retrospective dataJialun Zhou, N Kumarasamy, Rossana Ditangco, et al.
The Journal of Gene Medicine|January 19, 2005
Long-term survival and concomitant gene expression of ribozyme-transduced CD4+ T-lymphocytes in HIV-infected patientsJanet L Macpherson, Maureen P Boyd, Allison J Arndt, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 28, 2017
Effect of Combination Antiretroviral Therapy on HIV-1-specific Antibody-Dependent Cellular Cytotoxicity Responses in Subtype B- and Subtype C-Infected CohortsVijaya Madhavi, Archana Kulkarni, Ashwini Shete, et al.
AIDS (London, England)|July 17, 2007
Baseline factors prognostic of sustained virological response in patients with HIV-hepatitis C virus co-infectionGregory J Dore, Francesca J Torriani, Maribel Rodriguez-Torres, et al.
Vaccine|November 9, 2004
Evaluation in macaques of HIV-1 DNA vaccines containing primate CpG motifs and fowlpoxvirus vaccines co-expressing IFNgamma or IL-12C Jane Dale, Robert De Rose, Kim M Wilson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 17, 2015
Determinants of Weight Evolution Among HIV-Positive Patients Initiating Antiretroviral Treatment in Low-Resource SettingsDiana Huisin ʼt Veld, Eric Balestre, Jozefien Buyze, et al.
Pageof 33

Showing results (281-290 of 324) with videos related to

Sort By:
Pageof 33
AIDS (London, England)|June 15, 2021
Broadly neutralizing antibody responses in the longitudinal primary HIV-1 infection Short Pulse Anti-Retroviral Therapy at Seroconversion cohortLuke A Granger, Isabella Huettner, Franka Debeljak, et al.
The Lancet. HIV|November 6, 2016
Body composition and metabolic outcomes after 96 weeks of treatment with ritonavir-boosted lopinavir plus either nucleoside or nucleotide reverse transcriptase inhibitors or raltegravir in patients with HIV with virological failure of a standard first-line antiretroviral therapy regimen: a substudy of the randomised, open-label, non-inferiority SECOND-LINE studyMark A Boyd, Janaki Amin, Patrick W G Mallon, et al.
The Southeast Asian Journal of Tropical Medicine and Public Health|February 4, 2012
Accelerating the development of an AIDS vaccine: the AIDS vaccine for Asia Network (Avan)Punnee Pitisuttithum, Supachai Rerks-Ngarm, Joseph Chiu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 15, 2018
Risk of Suicidal Behavior With Use of Efavirenz: Results from the Strategic Timing of Antiretroviral Treatment TrialAlejandro Arenas-Pinto, Birgit Grund, Shweta Sharma, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 27, 2005
The TREAT Asia HIV Observational Database: baseline and retrospective dataJialun Zhou, N Kumarasamy, Rossana Ditangco, et al.
The Journal of Gene Medicine|January 19, 2005
Long-term survival and concomitant gene expression of ribozyme-transduced CD4+ T-lymphocytes in HIV-infected patientsJanet L Macpherson, Maureen P Boyd, Allison J Arndt, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 28, 2017
Effect of Combination Antiretroviral Therapy on HIV-1-specific Antibody-Dependent Cellular Cytotoxicity Responses in Subtype B- and Subtype C-Infected CohortsVijaya Madhavi, Archana Kulkarni, Ashwini Shete, et al.
AIDS (London, England)|July 17, 2007
Baseline factors prognostic of sustained virological response in patients with HIV-hepatitis C virus co-infectionGregory J Dore, Francesca J Torriani, Maribel Rodriguez-Torres, et al.
Vaccine|November 9, 2004
Evaluation in macaques of HIV-1 DNA vaccines containing primate CpG motifs and fowlpoxvirus vaccines co-expressing IFNgamma or IL-12C Jane Dale, Robert De Rose, Kim M Wilson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 17, 2015
Determinants of Weight Evolution Among HIV-Positive Patients Initiating Antiretroviral Treatment in Low-Resource SettingsDiana Huisin ʼt Veld, Eric Balestre, Jozefien Buyze, et al.
Pageof 33